-
1
-
-
0026844620
-
Heparin-induced thrombocytopenia
-
Chong B.H. Heparin-induced thrombocytopenia. Aust. N. Z. J. Med. 22:1992;145-152.
-
(1992)
Aust. N. Z. J. Med.
, vol.22
, pp. 145-152
-
-
Chong, B.H.1
-
2
-
-
0034235911
-
Heparin-induced thrombocytopenia: New evidence for the dynamic binding of purified anti-PF4-heparin antibodies to platelets and the resultant platelet activation
-
Newman P.M., Chong B.H. Heparin-induced thrombocytopenia: new evidence for the dynamic binding of purified anti-PF4-heparin antibodies to platelets and the resultant platelet activation. Blood. 96:2000;182-187.
-
(2000)
Blood
, vol.96
, pp. 182-187
-
-
Newman, P.M.1
Chong, B.H.2
-
3
-
-
0028854433
-
Antibodies to macromolecular platelet factor 4 heparin complexes in heparin-induced thrombocytopenia: A study of 44 cases
-
Amiral J., Bridey F., Wolf M., Boyer-Neumann C., Fressinaud E., Vissac A.M., Peynaud-Debayle E., Dreyfus M., Meyer D. Antibodies to macromolecular platelet factor 4 heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases. Thromb. Haemost. 73:2000;21-28.
-
(2000)
Thromb. Haemost.
, vol.73
, pp. 21-28
-
-
Amiral, J.1
Bridey, F.2
Wolf, M.3
Boyer-Neumann, C.4
Fressinaud, E.5
Vissac, A.M.6
Peynaud-Debayle, E.7
Dreyfus, M.8
Meyer, D.9
-
4
-
-
0029086769
-
Characterization of the structural requirements for a carbohydrate based anticoagulant with a reduced risk of inducing the immunological type of heparin-associated thrombocytopenia
-
Greinacher A., Alban S., Dummel V., Franz G., Mueller-Eckhardt C. Characterization of the structural requirements for a carbohydrate based anticoagulant with a reduced risk of inducing the immunological type of heparin-associated thrombocytopenia. Thromb. Haemost. 74:1995;886-892.
-
(1995)
Thromb. Haemost.
, vol.74
, pp. 886-892
-
-
Greinacher, A.1
Alban, S.2
Dummel, V.3
Franz, G.4
Mueller-Eckhardt, C.5
-
5
-
-
0033730964
-
Pathophysiology of heparin-induced thrombocytopenia
-
Fabris F., Ahmad S., Cella G., Jeske W.P., Walenga J.M., Fareed J. Pathophysiology of heparin-induced thrombocytopenia. Arch. Pathol. Lab. Med. 124:2000;1657-1666.
-
(2000)
Arch. Pathol. Lab. Med.
, vol.124
, pp. 1657-1666
-
-
Fabris, F.1
Ahmad, S.2
Cella, G.3
Jeske, W.P.4
Walenga, J.M.5
Fareed, J.6
-
6
-
-
0032747473
-
Functional heterogeneity of anti-heparin platelet factor 4 antibodies: Implications in the pathogenesis of the HIT syndrome. Clin
-
Ahmad S., Walenga J.M., Jeske W.P., Cella G., Fareed J. Functional heterogeneity of anti-heparin platelet factor 4 antibodies: implications in the pathogenesis of the HIT syndrome. Clin. Appl. Thromb. Haemost. 5(Suppl. 1):1995;S32-S37.
-
(1995)
Appl. Thromb. Haemost.
, vol.5
, Issue.SUPPL. 1
-
-
Ahmad, S.1
Walenga, J.M.2
Jeske, W.P.3
Cella, G.4
Fareed, J.5
-
7
-
-
0030463618
-
A diagnostic test for heparin-induced thrombocytopenia: Detection of platelet microparticles using flow cytometry
-
Lee D.H., Warkentin T.E., Denomme G.A., Hayward C.P.M., Kelton J.G. A diagnostic test for heparin-induced thrombocytopenia: detection of platelet microparticles using flow cytometry. Br. J. Haematol. 95:1996;724-731.
-
(1996)
Br. J. Haematol.
, vol.95
, pp. 724-731
-
-
Lee, D.H.1
Warkentin, T.E.2
Denomme, G.A.3
Hayward, C.P.M.4
Kelton, J.G.5
-
8
-
-
0034235401
-
Morphological analysis of microparticle generation in heparin-induced thrombocytopenia
-
Hughes M., Hayward C.P.M., Warkentin T.E., Horsewood P., Chorneyko K.A., Kelton J.G. Morphological analysis of microparticle generation in heparin-induced thrombocytopenia. Blood. 96:2000;188-194.
-
(2000)
Blood
, vol.96
, pp. 188-194
-
-
Hughes, M.1
Hayward, C.P.M.2
Warkentin, T.E.3
Horsewood, P.4
Chorneyko, K.A.5
Kelton, J.G.6
-
9
-
-
0032903688
-
Laboratory tests for heparin-induced thrombocytopenia: A multicenter study
-
Walenga J.M., Jeske W.P., Wood J.J., Ahmad S., Lewis B.E., Bakhos M. Laboratory tests for heparin-induced thrombocytopenia: a multicenter study. Semin. Hematol. 36(Suppl. 1):1999;22-28.
-
(1999)
Semin. Hematol.
, vol.36
, Issue.SUPPL. 1
, pp. 22-28
-
-
Walenga, J.M.1
Jeske, W.P.2
Wood, J.J.3
Ahmad, S.4
Lewis, B.E.5
Bakhos, M.6
-
10
-
-
0032170569
-
Heparin-induced thrombocytopenia: New insights into the impact of the FcγRIIa-R-H131 polymorphism
-
Carlsson L.E., Santoso S., Baurichter G., Kroll H., Papenberg S., Eichler P., Westerdaal N.A.C., Kiefel V., van de Winkel J.G.J., Greinacher A. Heparin-induced thrombocytopenia: new insights into the impact of the FcγRIIa-R-H131 polymorphism. Blood. 92:1998;1526-1531.
-
(1998)
Blood
, vol.92
, pp. 1526-1531
-
-
Carlsson, L.E.1
Santoso, S.2
Baurichter, G.3
Kroll, H.4
Papenberg, S.5
Eichler, P.6
Westerdaal, N.A.C.7
Kiefel, V.8
Van de Winkel, J.G.J.9
Greinacher, A.10
-
11
-
-
0029417137
-
On the role of platelet Fc gamma RIIa phenotype in heparin-induced thrombocytopenia
-
Brandt J.T., Isenhart C.E., Osborne J.M., Ahmed A., Anderson C.L. On the role of platelet Fc gamma RIIa phenotype in heparin-induced thrombocytopenia. Thromb. Haemost. 74:1995;1564-1572.
-
(1995)
Thromb. Haemost.
, vol.74
, pp. 1564-1572
-
-
Brandt, J.T.1
Isenhart, C.E.2
Osborne, J.M.3
Ahmed, A.4
Anderson, C.L.5
-
12
-
-
0028871912
-
Single amino acid mutation of Fcγ receptor is associated with the development of heparin induced thrombocytopenia
-
Burgess J.K., Lindeman R., Chesterman C.N., Berndt M.C. Single amino acid mutation of Fcγ receptor is associated with the development of heparin induced thrombocytopenia. Br. J. Haematol. 91:1995;761-766.
-
(1995)
Br. J. Haematol.
, vol.91
, pp. 761-766
-
-
Burgess, J.K.1
Lindeman, R.2
Chesterman, C.N.3
Berndt, M.C.4
-
13
-
-
0032935890
-
A mouse model for heparin-induced thrombocytopenia
-
Blank M., Eldor A., Sigal T., Ziporen L., Cines D.B., Arepally G., Afek A., Shoenfeld Y. A mouse model for heparin-induced thrombocytopenia. Semin. Hematol. 36(Suppl. 1):1999;12-16.
-
(1999)
Semin. Hematol.
, vol.36
, Issue.SUPPL. 1
, pp. 12-16
-
-
Blank, M.1
Eldor, A.2
Sigal, T.3
Ziporen, L.4
Cines, D.B.5
Arepally, G.6
Afek, A.7
Shoenfeld, Y.8
-
14
-
-
0034306781
-
Human anti-heparin platelet factor 4 antibodies are capable of activating primate platelets: Towards the development of a HIT model in primates
-
Ahmad S., Jeske W.P., Walenga J.M., Aldabbagh A., Iqbal O., Fareed J. Human anti-heparin platelet factor 4 antibodies are capable of activating primate platelets: towards the development of a HIT model in primates. Thromb. Res. 100:2000;47-54.
-
(2000)
Thromb. Res.
, vol.100
, pp. 47-54
-
-
Ahmad, S.1
Jeske, W.P.2
Walenga, J.M.3
Aldabbagh, A.4
Iqbal, O.5
Fareed, J.6
-
15
-
-
0031732776
-
In vitro efficacy of platelet glycoprotein IIb/IIIa antagonists in blocking platelet function in plasma of patients with HIT
-
Mak K., Kottke-Marchant K., Brooks L.M., Topol E.J. In vitro efficacy of platelet glycoprotein IIb/IIIa antagonists in blocking platelet function in plasma of patients with HIT. Thromb. Haemost. 80:1998;989-993.
-
(1998)
Thromb. Haemost.
, vol.80
, pp. 989-993
-
-
Mak, K.1
Kottke-Marchant, K.2
Brooks, L.M.3
Topol, E.J.4
-
16
-
-
0031278036
-
Effect of glycprotein IIb/IIIa antagonists on the HIT serum induced activation of platelets
-
Jeske W.P., Walenga J.M., Szatkowski E., Ero M., Herbert J.M., Hass S., Bkhos M. Effect of glycprotein IIb/IIIa antagonists on the HIT serum induced activation of platelets. Thromb. Res. 88:1997;271-281.
-
(1997)
Thromb. Res.
, vol.88
, pp. 271-281
-
-
Jeske, W.P.1
Walenga, J.M.2
Szatkowski, E.3
Ero, M.4
Herbert, J.M.5
Hass, S.6
Bkhos, M.7
-
17
-
-
0032895104
-
Clinical experience with combined treatment of thrombin inhibitors and GPIIb/IIIa inhibitors in patients with HIT
-
Walenga J.M., Jeske W.P., Wallis D.E., Bahkos M., Lewis B.E., Leya F., Fareed J. Clinical experience with combined treatment of thrombin inhibitors and GPIIb/IIIa inhibitors in patients with HIT. Semin. Thromb. Hemost. 25(Suppl. 1):1999;177-183.
-
(1999)
Semin. Thromb. Hemost.
, vol.25
, Issue.SUPPL. 1
, pp. 177-183
-
-
Walenga, J.M.1
Jeske, W.P.2
Wallis, D.E.3
Bahkos, M.4
Lewis, B.E.5
Leya, F.6
Fareed, J.7
-
18
-
-
0031044144
-
The glycoprotein IIb/IIIa antagonist c7E3 inhibits platelet aggregation in the presence of heparin-associated antibodies
-
Leim T.K., Teel R., Shukla S., Silver D. The glycoprotein IIb/IIIa antagonist c7E3 inhibits platelet aggregation in the presence of heparin-associated antibodies. J. Vasc. Surg. 25:1997;124-130.
-
(1997)
J. Vasc. Surg.
, vol.25
, pp. 124-130
-
-
Leim, T.K.1
Teel, R.2
Shukla, S.3
Silver, D.4
-
19
-
-
0022640930
-
A diagnostic test for heparin-induced thrombocytopenia
-
Sheridan D., Carter C., Kelton J.G. A diagnostic test for heparin-induced thrombocytopenia. Blood. 67:1986;27-30.
-
(1986)
Blood
, vol.67
, pp. 27-30
-
-
Sheridan, D.1
Carter, C.2
Kelton, J.G.3
-
20
-
-
0021792236
-
Heparin-induced thrombocytopenia and thrombosis: Detection and specificity of a platelet aggregating IgG
-
Sandler R.M., Seifer D.B., Morgan K., Pockros P.F., Wypych J., Weiss L.M., Schiffman S. Heparin-induced thrombocytopenia and thrombosis: detection and specificity of a platelet aggregating IgG. Am. J. Clin. Pathol. 83:1985;760-764.
-
(1985)
Am. J. Clin. Pathol.
, vol.83
, pp. 760-764
-
-
Sandler, R.M.1
Seifer, D.B.2
Morgan, K.3
Pockros, P.F.4
Wypych, J.5
Weiss, L.M.6
Schiffman, S.7
-
21
-
-
0028243705
-
Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complexes of heparin and platelet factor 4
-
Kelton J.G., Smith J.W., Warkentin T.E., Hayward C.P.M., Denomme G.A., Horsewood P. Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complexes of heparin and platelet factor 4. Blood. 83:1994;3232-3239.
-
(1994)
Blood
, vol.83
, pp. 3232-3239
-
-
Kelton, J.G.1
Smith, J.W.2
Warkentin, T.E.3
Hayward, C.P.M.4
Denomme, G.A.5
Horsewood, P.6
-
22
-
-
0030703541
-
Differences in specificity of heparin-dependent antibodies developed in heparin-induced thrombocytopenia and consequeces on cross-reactivity with danapariod sodium
-
Poupard C., Amiral J., Borg J.Y., Vissac A.M., Delahousse B., Gruel Y. Differences in specificity of heparin-dependent antibodies developed in heparin-induced thrombocytopenia and consequeces on cross-reactivity with danapariod sodium. Br. J. Haematol. 99:1997;273-280.
-
(1997)
Br. J. Haematol.
, vol.99
, pp. 273-280
-
-
Poupard, C.1
Amiral, J.2
Borg, J.Y.3
Vissac, A.M.4
Delahousse, B.5
Gruel, Y.6
-
23
-
-
0029878458
-
Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia
-
Amiral J., Wolf M., Fischer A.M., Boyer-Neumann C., Vissac A.M., Meyer D. Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia. Br. J. Haematol. 92:1996;954-959.
-
(1996)
Br. J. Haematol.
, vol.92
, pp. 954-959
-
-
Amiral, J.1
Wolf, M.2
Fischer, A.M.3
Boyer-Neumann, C.4
Vissac, A.M.5
Meyer, D.6
-
24
-
-
0035874509
-
Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia
-
Poulpard C., Iochmann S., Renard B., Herault O., Colombat P., Amerial J., Gruel Y. Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia. Blood. 97:2001;3300-3302.
-
(2001)
Blood
, vol.97
, pp. 3300-3302
-
-
Poulpard, C.1
Iochmann, S.2
Renard, B.3
Herault, O.4
Colombat, P.5
Amerial, J.6
Gruel, Y.7
-
25
-
-
0027283778
-
Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea pig, hamster and rat blood: Activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists
-
Cook N.S., Zerwes H.G., Tapparelli C., Powling M., Singh J., Mettemich R., Hagenback A. Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists. Thromb. Haemost. 70:1993;531-539.
-
(1993)
Thromb. Haemost.
, vol.70
, pp. 531-539
-
-
Cook, N.S.1
Zerwes, H.G.2
Tapparelli, C.3
Powling, M.4
Singh, J.5
Mettemich, R.6
Hagenback, A.7
-
26
-
-
0035140978
-
The effect of a novel glycoprotein IIb/IIIa antagonist, SR121566A, on platelet aggregation and activation in rhesus monkeys
-
Santillan M.K.O., Herring J., Hoppensteadt D.A., Jeske W., Herbert J.M., Fareed J. The effect of a novel glycoprotein IIb/IIIa antagonist, SR121566A, on platelet aggregation and activation in rhesus monkeys. Clin. Appl. Thromb. Hemost. 7:2001;10-15.
-
(2001)
Clin. Appl. Thromb. Hemost.
, vol.7
, pp. 10-15
-
-
Santillan, M.K.O.1
Herring, J.2
Hoppensteadt, D.A.3
Jeske, W.4
Herbert, J.M.5
Fareed, J.6
-
27
-
-
0032895104
-
Clinical experience with combined treatment of thrombin inhibitors and GPIIb/IIIa inhibitors in patients with HIT
-
Walenga J.M., Jeske W.P., Wallis D.E., Bakhos M., Lewis B.E., Leya F., Fareed J. Clinical experience with combined treatment of thrombin inhibitors and GPIIb/IIIa inhibitors in patients with HIT. Semin. Thromb. Hemost. 25(Suppl. 1):1999;77-81.
-
(1999)
Semin. Thromb. Hemost.
, vol.25
, Issue.SUPPL. 1
, pp. 77-81
-
-
Walenga, J.M.1
Jeske, W.P.2
Wallis, D.E.3
Bakhos, M.4
Lewis, B.E.5
Leya, F.6
Fareed, J.7
|